[Enoxacin in the treatment of asymptomatic bacteriuria in patients with prostatic adenoma].
Fifty patients suffering from prostatic adenoma with asymptomatic bacteriuria, were admitted to an open non comparative trial. Enoxacin was administered at the daily dosage of 300 mg every 12 hours for 10 days. Three cycles of treatment were performed during three consecutive months. Treatment efficacy was established by assessing patient symptoms related to the infection such as pollakiuria , nocturia, decreased flow rate, stranguria, daily temperature. Cultural tests were also performed. All observations were collected at baseline and at the end of each cycle of therapy. Cure was obtained in 43 patients (87, 75%), 1 patient (2,04%) relapsed, 5 patients (10.2%) withdrew because of inefficacy of treatment and 1 patient died of heart failure. No side effects were observed. These results suggest that enoxacin may be successfully used in the treatment of asymptomatic bacteriuria.
Cortecchia
W
W
Clinica Urologica Osp. Sant'Orsola-Bologna.
Beghelli
R
R
Frigola
M
M
Soli
M
M
Lo Cigno
M
M
Emili
E
E
D'Amato
G
G
Dal Pra
M L
ML
D000368:Aged; D001437:Bacteriuria / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D004341:Drug Evaluation; D015365:Enoxacin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000150:complications*
D015365:Enoxacin
Enoxacina nel trattamento della batteriuria asintomatica in pazienti affetti da adenoma prostatico.